CellVoyant, United Kingdom
Rafael Carazo Salas is Professor and Chair of Biomedical Sciences at the University of Bristol, and Founder and CEO of CellVoyant, an AI-first biotech company with a mission to accelerate the development of life-changing cell therapies that cure disease.
Rafael did a PhD at EMBL Heidelberg and postdoctoral work with Sir Paul Nurse in London and the Rockefeller University in New York before holding independent PI positions in ETH Zurich and at the Gurdon Institute in the University of Cambridge.
With over 25 years of interdisciplinary research experience, he has provided key contributions to the cell and systems biology fields and is a prominent figure in the field of bioimaging.
FATEVIEW™: AI-POWERED, NON-DESTRUCTIVE ‘LIVE’ CELL ANALYTICS AND CELL FATE FORECASTING
Wednesday, June 11, 2025
4:20 PM – 4:35 PM HK Time
FATEVIEW™: AI-POWERED, NON-DESTRUCTIVE ‘LIVE’ CELL ANALYTICS AND CELL FATE FORECASTING
Thursday, June 12, 2025
5:20 PM – 5:35 PM HK Time